SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Lal PathLabs informs about board meeting

23 Jul 2021 Evaluate

Dr Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Friday, July 30, 2021, to consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2021 and to consider the proposal of declaration of interim dividend, if any, for the Financial Year 2021-22.

The above information is a part of company’s filings submitted to BSE.


Dr. Lal Pathlabs Share Price

1439.80 22.45 (1.58%)
21-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×